Regeneron Pharmaceuticals, Inc.
États‑Unis d’Amérique
Nouveaux brevets et marques déposées la semaine dernière
Dernière mise à jour : 2026-09-19
Sommaire
Brevets |
Marques |
|
 |
10 | 2 |
 |
0 | 0 |
 |
0 | 0 |
 |
0 |
Commandez votre montre hebdomadaire Regeneron Pharmaceuticals, Inc.
1
Viewing 1 - 12 of 12
marques
brevets
| # | ID | Juridiction | Title |
|---|---|---|---|
| 1 | 19694417 |
|
COMBINATION THERAPY TO TREAT BRAIN CANCER |
| 2 | 19666697 |
|
Lyophilized Formulations of AAV Drug Products |
| 3 | 19675162 |
|
METHOD FOR VIRAL INACTIVATION |
| 4 | 19471712 |
|
METHODS OF IMPROVING TRANSPLANT SURVIVAL USING IL-2 RECEPTOR GAMMA CHAIN ANTIBODIES |
| 5 | 19399234 |
|
METHODS FOR TREATING PEANUT ALLERGY AND ENHANCING PEANUT ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING AN IL-4R ANTAGONIST |
| 6 | 19277925 |
|
NUCLEIC ACID CONSTRUCTS AND METHODS OF USE |
| 7 | 19674773 |
|
METHODS FOR DELIVERING AGENTS WITH PRE-FILLED SYRINGES TO MINIMIZE INTRAOCULAR INFLAMMATION |
| 8 | 19565633 |
|
ANTI-NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA 1 (NY-ESO-1) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF |
| 9 | 19673041 |
|
DRUG DELIVERY DEVICE FIXTURE FOR TESTING SYSTEM AND METHODS |
| 10 | 19686394 |
|
METHODS FOR REDUCING EOSINOPHILIC INFILTRATION BY ADMINISTERING AN ANTI-INTERLEUKIN-4 RECEPTOR (IL4R) ANTIBODY |
1